Live attenuated Bordetella strains as a single dose vaccine against whooping cough

Details for Australian Patent Application No. 2007224734 (hide)

Owner Institut National De La Sante Et De La Recherche Medicale (INSERM) Institut Pasteur de Lille

Inventors Locht, Camille; Mielcarek, Nathalie; Debrie, Anne-Sophie; Raze, Dominique; Bertout, Julie

Agent Shelston IP

Pub. Number AU-A-2007224734

PCT Pub. Number WO2007/104451

Priority 60/780,827 10.03.06 US; 60/817,430 30.06.06 US

Filing date 7 March 2007

Wipo publication date 20 September 2007

International Classifications

C12N 1/36 (2006.01) Micro-organisms, e.g. protozoa - Adaptation or attenuation of cells

A61K 39/10 (2006.01) Medicinal preparations containing antigens or antibodies - Brucella

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/104451 Priority application(s): WO2007/104451

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224737-Cosmetic preparations with an additive from the baobab tree

2007224708-Method for the synthesis of organic acid esters of 5-hydroxymethylfurfural and their use